Michael O'Shaughnessy
Affiliations: | University of British Columbia, Vancouver, Vancouver, BC, Canada |
Area:
Neuroscience BiologyGoogle:
"Michael O'Shaughnessy"Mean distance: 106866
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Phillips P, Bonner S, Gataric N, et al. (2005) Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term follow-up. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 41: 1483-97 |
| Wood E, Montaner JSG, Braitstein P, et al. (2004) Elevated rates of antiretroviral treatment discontinuation among HIV-infected injection drug users: Implications for drug policy and public health International Journal of Drug Policy. 15: 133-138 |
| Palepu A, Tyndall MW, Li K, et al. (2003) Alcohol use and incarceration adversely affect HIV-1 RNA suppression among injection drug users starting antiretroviral therapy. Journal of Urban Health : Bulletin of the New York Academy of Medicine. 80: 667-75 |
| Bedell R, Heath KV, Hogg RS, et al. (2003) Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings. Antiviral Therapy. 8: 379-84 |
| Wood E, Hogg RS, Yip B, et al. (2003) Higher baseline levels of plasma human immunodeficiency virus type 1 RNA are associated with increased mortality after initiation of triple-drug antiretroviral therapy. The Journal of Infectious Diseases. 188: 1421-5 |
| Wood E, Hogg RS, Yip B, et al. (2003) Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 x 10(9) cells/L. Annals of Internal Medicine. 139: 810-6 |
| Wood E, Montaner JS, Bangsberg DR, et al. (2003) Expanding access to HIV antiretroviral therapy among marginalized populations in the developed world. Aids (London, England). 17: 2419-27 |
| Wood E, Spittal PM, Kerr T, et al. (2003) Requiring help injecting as a risk factor for HIV infection in the Vancouver epidemic: implications for HIV prevention. Canadian Journal of Public Health = Revue Canadienne De Santé Publique. 94: 355-9 |
| Wood E, Montaner JS, Tyndall MW, et al. (2003) Prevalence and correlates of untreated human immunodeficiency virus type 1 infection among persons who have died in the era of modern antiretroviral therapy. The Journal of Infectious Diseases. 188: 1164-70 |
| Wood E, Montaner JS, Yip B, et al. (2003) Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 169: 656-61 |